280 related articles for article (PubMed ID: 21660488)
1. Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.
Tan Y; Chen Y; You Q; Sun H; Li M
J Mol Model; 2012 Mar; 18(3):1023-36. PubMed ID: 21660488
[TBL] [Abstract][Full Text] [Related]
2. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
Durdagi S; Duff HJ; Noskov SY
J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
[TBL] [Abstract][Full Text] [Related]
3. In silico prediction of hERG inhibition.
Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
[TBL] [Abstract][Full Text] [Related]
4. A binary QSAR model for classification of hERG potassium channel blockers.
Thai KM; Ecker GF
Bioorg Med Chem; 2008 Apr; 16(7):4107-19. PubMed ID: 18243713
[TBL] [Abstract][Full Text] [Related]
5. Combining structure- and ligand-based approaches for studies of interactions between different conformations of the hERG K+ channel pore and known ligands.
Coi A; Bianucci AM
J Mol Graph Model; 2013 Nov; 46():93-104. PubMed ID: 24185260
[TBL] [Abstract][Full Text] [Related]
6. GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers.
Ermondi G; Visentin S; Caron G
Eur J Med Chem; 2009 May; 44(5):1926-32. PubMed ID: 19110341
[TBL] [Abstract][Full Text] [Related]
7. A composite model for HERG blockade.
Kramer C; Beck B; Kriegl JM; Clark T
ChemMedChem; 2008 Feb; 3(2):254-65. PubMed ID: 18061919
[TBL] [Abstract][Full Text] [Related]
8. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
Aronov AM
J Med Chem; 2006 Nov; 49(23):6917-21. PubMed ID: 17154521
[TBL] [Abstract][Full Text] [Related]
9. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Cavalli A; Poluzzi E; De Ponti F; Recanatini M
J Med Chem; 2002 Aug; 45(18):3844-53. PubMed ID: 12190308
[TBL] [Abstract][Full Text] [Related]
10. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.
Thai KM; Ecker GF
Mol Divers; 2009 Aug; 13(3):321-36. PubMed ID: 19219559
[TBL] [Abstract][Full Text] [Related]
11. Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation.
Diller DJ; Hobbs DW
J Comput Aided Mol Des; 2007 Jul; 21(7):379-93. PubMed ID: 17549583
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
[TBL] [Abstract][Full Text] [Related]
13. A critical assessment of combined ligand- and structure-based approaches to HERG channel blocker modeling.
Du-Cuny L; Chen L; Zhang S
J Chem Inf Model; 2011 Nov; 51(11):2948-60. PubMed ID: 21902220
[TBL] [Abstract][Full Text] [Related]
14. A novel approach using pharmacophore ensemble/support vector machine (PhE/SVM) for prediction of hERG liability.
Leong MK
Chem Res Toxicol; 2007 Feb; 20(2):217-26. PubMed ID: 17261034
[TBL] [Abstract][Full Text] [Related]
15. Prediction of hERG potassium channel affinity by the CODESSA approach.
Coi A; Massarelli I; Murgia L; Saraceno M; Calderone V; Bianucci AM
Bioorg Med Chem; 2006 May; 14(9):3153-9. PubMed ID: 16426850
[TBL] [Abstract][Full Text] [Related]
16. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
17. General Purpose 2D and 3D Similarity Approach to Identify hERG Blockers.
Schyman P; Liu R; Wallqvist A
J Chem Inf Model; 2016 Jan; 56(1):213-22. PubMed ID: 26718126
[TBL] [Abstract][Full Text] [Related]
18. Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools.
Moorthy NS; Ramos MJ; Fernandes PA
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):317-24. PubMed ID: 23560722
[TBL] [Abstract][Full Text] [Related]
19. Machine-learning technique, QSAR and molecular dynamics for hERG-drug interactions.
Das NR; Sharma T; Toropov AA; Toropova AP; Tripathi MK; Achary PGR
J Biomol Struct Dyn; 2023; 41(23):13766-13791. PubMed ID: 37021352
[TBL] [Abstract][Full Text] [Related]
20. ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches.
Wang S; Sun H; Liu H; Li D; Li Y; Hou T
Mol Pharm; 2016 Aug; 13(8):2855-66. PubMed ID: 27379394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]